Canada markets closed

Absci Corporation (ABSI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.5800+0.1250 (+2.81%)
At close: 04:00PM EDT
4.5200 -0.06 (-1.31%)
After hours: 05:46PM EDT

Absci Corporation

18105 SE Mill Plain Boulevard
Vancouver, WA 98683
United States
360 949 1041
https://www.absci.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees155

Key Executives

NameTitlePayExercisedYear Born
Mr. Sean McClainFounder, CEO, President & Director1.01MN/A1990
Dr. Zachariah Jonasson Ph.D.Chief Business Officer & CFO331.64kN/A1973
Dr. Andreas Busch Ph.D.Chief Innovation Officer & Member of Scientific Advisory Board1.13MN/A1963
Mr. Todd Bedrick CPASenior VP & Chief Accounting OfficerN/AN/AN/A
Mr. Alexander Khan CPAVP of Finance & Head of Investor RelationsN/AN/AN/A
Ms. Karin WierinckChief People OfficerN/AN/AN/A
Melissa Patterson Ph.D.Chief of StaffN/AN/AN/A
Jens Plassmeier Ph.D.Senior VP of Biologics Discovery TechnologyN/AN/AN/A
Mr. Wen ShaChief of StaffN/AN/AN/A
Dr. Christine Lemke D.V.M., M.B.A., Ph.D.Senior Vice President of Portfolio & Growth StrategyN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Corporate Governance

Absci Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.